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Introduction: Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) may be suitable for myocardial
repair. While their functional and structural properties have been extensively investigated, their response to
ischemia-like conditions has not yet been clearly defined.
Methods: iPS-CMs were differentiated and enriched from murine induced pluripotent stem cells expressing
enhanced green fluorescent protein (eGFP) and puromycin resistance genes under the control of an α-myosin
heavy chain (α-MHC) promoter. iPS-CMs maturity and function were characterized by microscopy, real-time PCR,
calcium transient recordings, electrophysiology, and mitochondrial function assays, and compared to those from
neonatal murine cardiomyocytes. iPS-CMs as well as neonatal murine cardiomyocytes were exposed for 3 hours to
hypoxia (1% O2) and glucose/serum deprivation, and viability, apoptosis markers, reactive oxygen species, mitochondrial
membrane potential and intracellular stress signaling cascades were investigated. Then, the iPS-CMs response to
mesenchymal stromal cell-conditioned medium was determined.
Results: iPS-CMs displayed key morphological and functional properties that were comparable to those of neonatal
cardiomyocytes, but several parameters indicated an earlier iPS-CMs maturation stage. During hypoxia and glucose/serum
deprivation, iPS-CMs exhibited a significantly higher proportion of poly-caspase-active, 7-aminoactinomycin D-positive
and TUNEL-positive cells than neonatal cardiomyocytes. The average mitochondrial membrane potential was reduced
in “ischemic” iPS-CMs but remained unchanged in neonatal cardiomyocytes; reactive oxygen species production was
only increased in “ischemic” iPS-CMs, and oxidoreductase activity in iPS-CMs dropped more rapidly than in neonatal
cardiomyocytes. In iPS-CMs, hypoxia and glucose/serum deprivation led to upregulation of Hsp70 transcripts and decreased
STAT3 phosphorylation and total PKCε protein expression. Treatment with mesenchymal stromal cell-conditioned medium
preserved oxidoreductase activity and restored pSTAT3 and PKCε levels.
Conclusion: iPS-CMs appear to be particularly sensitive to hypoxia and nutrient deprivation. Counteracting the ischemic
susceptibility of iPS-CMs with mesenchymal stromal cell-conditioned medium may help enhance their survival and efficacy
in cell-based approaches for myocardial repair.* Correspondence: andreja.brodarac@charite.de
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Transplantation of cardiomyocytes (CMs) into injured
myocardium has been shown to improve contractile func-
tion in animal models of heart disease [1,2]. With advances
in genetic reprogramming technology, creation of induced
pluripotent stem cells (iPSCs) and improvements in differ-
entiation protocols, it is now possible to produce large
quantities of patient-specific, autologous CMs (induced
pluripotent stem cell-derived cardiomyocytes; iPS-CMs)
in vitro [3,4]. However, low retention, survival, and engraft-
ment of transplanted CMs in the ischemic heart greatly
hamper clinical application of these cells [5]. Cell loss is
dramatic even when cell types with high tolerance to
ischemia, such as mesenchymal stromal cells (MSCs), are
transplanted into infarcted myocardium [6]. A detailed
understanding of the cellular response to ischemia-like
stress is therefore necessary for improving the efficacy of
cell-based myocardial regeneration. Structurally and func-
tionally, iPS-CMs were shown to display properties of fetal
or neonatal CMs [7-10]. In contrast to adult mature CMs,
which depend on oxidative metabolism for ATP synthesis,
immature CMs can generate ATP through glycolysis and
should to be more resistant to hypoxia [11,12]. We there-
fore analyzed the response of murine iPS-CMs and their
neonatal murine counterparts (N-CMs) to hypoxia and glu-
cose/serum deprivation (GSD) in vitro, and also tested the
potential of paracrine factors secreted from bone marrow-
derived multipotent MSCs to protect iPS-CMs from dele-
terious effects of “simulated in vitro ischemia” [13,14].
Methods
Induced pluripotent stem cell differentiation and
purification
Murine iPSCs generated from 129S4/Sv4JaeJ x C57Bl/6 tail
tip fibroblasts were generously provided by the Jaenisch
group [15]. These iPSCs were genetically modified to
express enhanced green fluorescent protein (GFP) and
puromycin resistance genes under the control of an
α-myosin heavy chain promoter as previously described for
murine embryonic stem cells [16]. Undifferentiated iPSCs
were grown on irradiated mouse embryonic fibroblasts
(CellSystems, Troisdorf, Germany) in Dulbecco’s modified
Eagle's Medium (DMEM) supplemented with 15% fetal
bovine serum (FBS), 1% non-essential amino acids, 50 μM
β-mercaptoethanol (all from Life Technologies, Darmstadt,
Germany) and 1000 U/ml leukaemia inhibitory factor (LIF)
(Merck Millipore, Darmstadt, Germany). Cardiomyocyte
differentiation of iPSCs was performed as summarized in
Figure 1A. One million iPSCs were incubated in a Petri dish
on a horizontal shaker (60 rpm) in 14 ml differentiation
medium composed of Iscove’s modified Dulbecco’s medium
(IMDM), 20% FBS, 1% non-essential amino acids, 0.1 mM
β-mercaptoethanol (all from Life Technologies) and
30 μg/ml ascorbic acid (Wako Chemicals USA Inc.,Richmond, VA, USA). Two days after initiation of differen-
tiation, embryoid bodies (EBs) were transferred into 250 ml
spinner flasks (Integra Biosciences, Fernwald, Germany) at
a density of 30,000 EBs per 200 ml differentiation medium.
Since iPS-CMs expressed both enhanced GFP and
puromycin resistance, the addition of 8 μg/ml puromycin
(PAA, Cölbe, Germany) from differentiation day 9 until day
16 resulted in a highly pure population of GFP-positive and
spontaneously contracting CMs. Fresh puromycin was
added every second day. On differentiation day 16,
iPS-CMs were dissociated with 0.25% trypsin-
ethylenediaminetetraacetic acid (EDTA) and their purity
was assessed by flow cytometry (FACS Calibur, BD
Biosciences, San Diego, CA, USA). For all subsequent
analyses, dissociated CMs were plated on fibronectin-
coated plates and maintained for an additional 5 days as
described below.
Neonatal mouse cardiomyocytes
N-CMs were purchased from ScienceCell (Provitro, Berlin,
Germany), where they were characterized by immunostain-
ing with antibodies specific to smooth muscle actin, sarco-
meric alpha-actinin, and tropomyosin. Their purity was
estimated to be between 95 and 97%, with viability approxi-
mately 98%. N-CMs were cultured in medium that select-
ively promotes CM growth to preserve their purity and
prevent outgrowth by non-CMs. It consisted of basal
medium (cat. no.6201), 5% FBS (cat. no. 0025), 1% of spe-
cific CM growth supplement (cat. no. 6252) and 1% of
penicillin/streptomycin solution (cat. no. 0503) (all from
Provitro). At confluency, after 10 to 12 days in culture,
cells were trypsinized and 40,000 cells/well plated on
fibronectin-coated plates for subsequent analyses.
Immunocytochemistry
On differentiation day 21, cells were fixed with 4% buffered
paraformaldehyde (PFA) and permeabilized with 0.1%
Triton X-100. Followed by blocking in 5% goat serum, cells
were stained with anti-sarcomeric-α-actinin (clone EA-53,
1:400; Sigma, Sigma-Aldrich, Steinheim, Germany) in 0.8%
bovine serum albumin/phosphate-buffered saline (BSA/
PBS). After washing in PBS, incubation with anti-mouse-
igG1 Alexa Fluor 555 was performed (1:500;) in 0.8% BSA/
PBS (Sigma-Aldrich, Steinheim, Germany) for 60 minutes at
room temperature and nuclei were stained with 2 μg/ml
Hoechst 33342 (Life Technologies). Images were ac-
quired using the high content screening (HCS) imaging
system Operetta® and Harmony® software (PerkinElmer,
Waltham, MA, USA).
Electron microscopy
Cells were fixed by immersion with 3 to 6% (v/v) glutaral-
dehyde in 0.1 M sodium cacodylate buffer, rinsed twice for
15 minutes in 0.1 M cacodylate buffer, pH 7.2, post-fixed
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Figure 1 Differentiation of murine induced pluripotent stem cells (iPSCs) into cardiomyocytes (CMs). (A) Schematic representation of the experimental
protocol. (B) Representative images of embryoid bodies (EBs) composed of a mixed cell population containing areas of GFP-expressing CMs on differentiation
day 9. Purified cardiac clusters were generated by selection with puromycin until day 16. (C) Flow cytometry analysis of GFP-positive iPS-CMs after
trypsinization of puromycin-selected cardiac clusters on day 16. (D) α-Actinin (red) staining of puromycin-selected CMs (green) on differentiation day
21. (E) Effect of hypoxia and glucose/serum deprivation on poly-caspase activity in iPS-CMs. The baseline level of poly-caspase active in iPS-CMs was
determined in normoxia and full medium. *P≤ 0.05, versus normoxia for individual datasets (Bonferroni test); **P < 0.001, overall by analysis of variance.
FBS, fetal bovine serum; GFP, green fluorescent protein; Glu, glucose; PI, propidium iodide.
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pH 7.2, at room temperature in the dark, rinsed again,
dehydrated with acetone and embedded in araldite CY212
(Durcupan ACM, Fluka, Sigma, St.Louis, MO, USA). Ultra-
thin sections were cut at grey interference colour (25 to
30 nm) with a 35°-diamond knife (Diatome, Hatfield, PA,
USA) on an Ultracut E (Leica, Buffalo Grove, IL, USA),
mounted on formvar/carbon-coated copper grids and con-
trasted with uranyl acetate and lead citrate. Microscopy was
performed with a Zeiss EM109 (80 kV, 500 μm condenser
1 aperture, 200 μm condenser 2 aperture, 30um objective
aperture; Carl Zeis Jena, Germany) equipped with a
temperature-stabilized wide angle YAC-CCD camera at the
side entry port (1024 × 1024 pixel, 12-bit greyscale/pixel;info@trs-system.de). Magnification was calibrated with a
cross grating replica (2,160 lines/mm, d = 0.463 μm).
Recording of intracellular calcium transients
iPS-CMs cultured in chamber slides were loaded with
2 μM Fura 2-AM (Molecular Probes, Life Technologies,
Carlsbad, CA, USA) in Hank’s balanced salts modified
buffer (HBSS, pH 7.4) for 15 minutes at 37°C, and washed
twice for 15 minutes in HBSS. The slides were placed on a
temperature-regulated microscope stage and kept at 37°C.
Fluorescence images were acquired using the IonWizard
Transient Analysis software package (IonOptix Limited,
Dublin, Ireland) together with an Olympus IX70 inverted
fluorescence microscope (40× Fura-UV objective) (Myocyte
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Limited). The data shown represent the average of Fura-2
ratio (R340/380) for 35 iPS-CMs from three independent
experiments.
Determination of oxygen consumption rate
For oxygen consumption rate (OCR) quantification, 20,000
iPS-CMs were seeded into each well of a Seahorse XFe96
cell culture plate and cultured for 2 days to ensure firm
adherence to the cell culture plate. On the day of measure-
ment, the medium was changed to pre-warmed Seahorse
Assay medium and OCR determined according to the
manufacturer’s instructions using the Seahorse XF Cell Mito
Stress Kit (all from Seahorse Bioscience, North Billerica,
MA, USA). Basal respiration was measured in unstimulated
cells during three cycles of measurement. Afterwards,
oligomycin (1 μM) was added to quantify ATP produc-
tion followed by carbonyl cyanide-4-(trifluoromethoxy)-
phenylhydrazone (FCCP; 1 μM) injection to assess maximal
cellular respiration (respiratory capacity). Finally, antimycin
A and rotenone (1 μM) treatment revealed the amount of
non-mitochondrial respiration.
Electrophysiology
iPS-CMs and N-CMs aggregates were dispersed using col-
lagenase B [17] or trypsin/EDTA, respectively, followed by
addition of neutralization solution (all Provitro). Single cells
were incubated at 37°C in DMEM/20% metal calf serum
(FCS) for 24 to 36 hours before measurements were per-
formed. Action potentials (APs) of spontaneously beating
CMs were measured by means of the whole-cell current
clamp technique using an EPC-9 amplifier and the PULSE
software package (Heka Elektronik, Lambrecht, Germany).
The experiments were performed at 37°C in standard extra-
cellular solution containing (in mMol/l) 140 NaCl, 5.4
KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES and 10 glucose, or
136 NaCl, 5.4 KCl, 0.33 NaH2PO4, 1 MgCl2, 10 glucose,
5 HEPES and 1.8 CaCl2 (pH 7.4, adjusted with NaOH).
Patch-clamp pipettes, prepared from glass capillary tubes
(Harvard Apparatus Ltd, Kent, UK) with a two-stage hori-
zontal puller (DMZ Universal Puller, Munich, Germany),
had a resistance of 2 to 3 MΩ when filled with intracellular
solution containing (in mMol/l) 50 KCl, 80 KAspartate, 1
MgCl2, 3 MgATP, 10 EGTA and 10 HEPES (pH 7.4).
Isoproterenol and carbachol (Sigma-Aldrich, Steinheim,
Germany) were prepared freshly before the experiments
and applied using gravitational flow. Data were analyzed
off-line with custom-made analysis software (kindly pro-
vided by Prof. Philipp Sasse, University of Bonn, Germany).
Exposure of cells to hypoxia and glucose/serum
deprivation
Puromycin-selected iPSC-derived cardiac clusters were
dissociated at day 16 of differentiation with 0.25% trypsin-EDTA and plated on a 2.5 μg/ml fibronectin-coated
96-well plate at the density of 40,000 cells/well in high-
glucose DMEM, supplemented with 15% FBS, 1% non-
essential amino acids, and 50 μM β-mercaptoethanol
(all from Life Technologies). Puromycin (8 μg/ml) was
maintained in culture medium and refreshed every second
day to prevent the outgrowth of any proliferating cells that
may contaminate purified CM preparations. Five days
after plating and culture in a humidified incubator (CB
210; Binder, Tuttlingen, Germany) at 37°C, 5% CO2 and
atmospheric oxygen concentration (21%), parallel plates
were transferred to an incubator (CB 150; Binder) main-
tained at 1% O2 and incubated for 3, 5 or 7 hours in: a)
basal DMEM, high glucose supplemented with both 10%
FBS and glucose; b) DMEM, no glucose containing only
10% FBS; c) DMEM, high glucose containing only glucose;
or d) DMEM, no glucose lacking both serum and glucose.
Control cells were kept for equivalent time periods under
normoxic standard conditions. After establishing the
conditions leading to reproducibly detectable cell damage,
all subsequent experiments were performed by incubating
iPS-CMs and N-CMs for 3 hours in hypoxia (1% O2) in
glucose- and serum-deprived medium as summarized in
Figure 1A. The analyses of various cell viability parameters
were performed at the end of the hypoxia period, without
reoxygenation. The number and density of iPS-CMs and
N-CMs incubated under control conditions was similar as
determined by cell counting at the end of the incubation
period, using the Operetta® HCS.
Caspase activity
For detection of cells undergoing apoptosis, iPS-CMs and
N-CMs were plated in 96-well ViewPlates (PerkinElmer).
Poly-caspase-active cells were visualized using the fluores-
cent poly-caspase reagent, R-VAD-FMK (SR-FLICA;
Biomol, Hamburg, Germany), a sensitive and early detector
of apoptosis initiation. Following incubation under control
conditions or hypoxia and/or GSD, medium was aspirated,
60 μl/well of SR-FLICA reagent was added, and cells were
incubated for the next 45 minutes at 21% O2. Cells were
washed with Dulbecco’s PBS, fixed with 4% PFA, and
nuclei were stained with 2 μg/ml Hoechst 33342 (Life
Technologies). Finally, cells were visualized and quanti-
tatively analyzed using the Operetta® HCS. In addition,
the activity of caspase-3/7, -8 and -9 was assessed using
specific substrates reconstituted in respective caspase-
Glo-3/7, -8 or -9 buffer (Promega, Mannheim, Germany).
Following incubation in hypoxia/GSD and control condi-
tions, 60 μl of reagent was added to an equal volume of
medium in 96-well transparent plates (Greiner Bio-One,
Frickenhausen, Germany), and incubated for 1 hour at room
temperature; 100 μl from each well was then transferred to
opaque 96-well plates and luminescence, directly propor-
tional to the amount of caspase activity, was recorded using
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Technologies, Bad Wildbad, Germany).
7-aminoactinomycin D staining
Late apoptotic and necrotic cells were detected using
7-aminoactinomycin D (7-AAD) (Biomol). 7-AAD was
reconstituted in 260 μl DMSO and diluted 1:250 in DMEM
(high glucose) supplemented with 10% FBS. Following incu-
bation in hypoxia or control conditions, 60 μl of reagent was
added to cells, which were then incubated for 15 minutes at
room temperature. Cells were fixed with 4% PFA and nuclei
stained with Hoechst 33342. Quantitation of 7-AAD-
positive cells was performed using the Operetta® HCS.
TUNEL staining
DNA fragmentation was detected using the in situ cell death
detection kit (Roche, Mannheim, Germany). Cells were fixed
with 4% PFA for 60 minutes at room temperature and
permeabilized with 0.25% Triton X-100. After washing in
PBS, reagent was added for 60 minutes at 37°C followed by
Hoechst 33342 staining. Cells were visualized and quantita-
tively analyzed using the Operetta® HCS.
Mitochondrial membrane integrity
Analysis of the mitochondrial membrane potential was
performed in control cells and cells subjected to hypoxia/
GSD using the JC-1 Mitochondrial Membrane Potential
Probe (Life Technologies). JC-1 was added into medium
at 2 μM final concentration for 30 minutes incubation at
room temperature. Then, cells were fixed with 4% PFA
and nuclei stained with Hoechst 33342. The loss of
“granulated” JC-1 staining in CMs and conversion into a
homogenous staining pattern indicated breakdown of the
mitochondrial membrane potential [18]. Quantification
was performed using the Operetta® HCS.
Mitochondrial transmembrane potential
The mitochondrial transmembrane potential was measured
using the tetramethylrhodamine methyl ester (TMRM)
fluorescence method (Life Technologies). TMRM dye was
added to the medium at 125 nM final concentration for
30 minutes incubation at 37°C, followed by 3 minutes
incubation with Hoechst 33342. The loss of mitochondrial
membrane potential causes TMRM to leak from mito-
chondria, resulting in a loss of fluorescence intensity. Live
images of cells were recorded for TMRM fluorescence
and quantitation of fluorescence intensity was performed
using the Operetta® HCS.
Reactive oxygen species measurement
Oxidative stress induced by reactive oxygen species (ROS)
was measured using CellROX® Deep Red Reagent (Life
Technologies). CellROX® reagent was added at a final con-
centration of 5 μM to the cells and incubated for 30 minutesat 37°C. After washing in PBS, cells were fixed with 4%
PFA and nuclei stained with Hoechst 33342. Images were
acquired and quantification of the fluorescence signal was
performed using the Operetta® HCS.
MTS assay
Metabolic activity was analyzed using the colorimetric
CellTiter 96 AQueous Non-Radioactive Cell Prolifera-
tion Assay (Promega), based on the reduction of
tetrazolium dye MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) to its insoluble formazan
by NADPH-dependent oxidoreductases. Following
3 hours incubation (40,000 CMs/well) in 1% O2 in
hypoxia/GSD or control conditions, 70 μl of the MTS/
PMS solution was added at 50 μl medium/well and
incubated for 4 hours at 21% O2. Absorbance was
measured at 490 nm directly in the 96-well plate using
a SpectraMax Plus384 Absorbance Microplate Reader
(Molecular Devices, Sunnyvale, CA, USA). The num-
ber of cells/well was counted using the Operetta® HCS,
and was confirmed to be similar between experimental
groups. Blank values from wells without cells were
subtracted.
ATP quantification
Cardiomyocyte ATP content was analyzed using the
CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Briefly, 60 μl reagent (CellTiter-Glo buffer/substrate) was
added (1:1) to 40,000 CMs/well cultured in 96-well plates
following incubation in hypoxia/GSD or control condi-
tions, and the plate was placed on an orbital shaker at
room temperature for 2 minutes (200 rpm). The content
of the plate was left to equilibrate for an additional
10 minutes at room temperature, before 100 μl from each
well were transferred to opaque 96-well plates and
luminescence was recorded using a Mithras LB 940
Multimode Microplate Reader (Berthold Technologies).
The number of cells/well was counted using the Operetta®
HCS and was confirmed to be similar between experi-
mental groups. Blank values from cell-free wells filled
with medium and CellTiter-Glo buffer/substrate were
substracted.
Preparation of mesenchymal stromal cell-conditioned
medium and fibroblast-conditioned medium
Bone marrow-derived MSCs were isolated from 8-week-
old C57BL/6 mice and characterized as previously
described [19]. The local Animal Ethics Committee
(Deutsches Herzzentrum and Charite-Universitätsmedizin
Berlin) granted approval, and all procedures conformed to
the guidelines from Directive 2010/63/EU of the European
Parliament. Fibroblasts were isolated from CF-1 mouse
strain at E13.5-E14.5 according to standard protocols.
Fibroblasts and MSCs were grown until 80 to 90%
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Germany) supplemented with 5% FBS and 2.5 ng/ml
recombinant human basic fibroblast growth factor
(Peprotech, Hamburg, Germany) in 21% O2. For the col-
lection of conditioned medium, cells were washed
thoroughly twice with Dulbecco's PBS and cultured in
serum/glucose-deprived medium at 1% O2 for 72 hours.
After 72 hours, conditioned medium was collected and
centrifuged for 5 minutes at 300 x g at room temperature.
Equivalent medium kept under the same conditions
in culture flasks without cells was used as a control. Cell
viability after 72 hours exposure to hypoxia/GSD was
evaluated by Trypan blue exclusion.
To determine the effect of MSC-conditioned medium
(MSC-CoM) and fibroblast-conditioned medium (FB-CoM)
on the viability of iPS-CMs exposed to hypoxia and nutrient
deprivation, iPS-CMs and N-CMs cells maintained under
baseline conditions (DMEM in 15% FBS and glucose, 21%
O2) were washed twice with Dulbecco's PBS, and standard
culture medium was replaced with DMEM without FBS
and without glucose or with MSC-CoM/FB-CoM (60 μl/
well in a 96-well plate) for 3 hours incubation at 1% O2. Cell
viability parameters were analyzed immediately after the
experiment.
RNA extraction, cDNA synthesis and real-time PCR
Total RNA was extracted using the RNeasy Mini Kit
(Qiagen, Hilden, Germany); 5 μg RNA per sample were
separated on 1% agarose gels to confirm RNA integrity, and
RNA concentration and quality were assessed by spectro-
photometry. First-strand cDNA was synthesized from 1 μg
total RNA using Oligo (dT) primers and Superscript™ II
RNase Reverse Transcriptase (Life Technologies). Quantifi-
cation of selected genes by real-time PCR was performed in
triplicate using the Mastercycler® ep realplex (Eppendorf,
Hamburg, Germany) with SYBR Green and PCR Master
Mix (Life Technologies). Each reaction consisted of 1 μl
cDNA, 2.5 μl primer (5 μM) and 21.5 μl reaction buffer
(Platinum SYBR Green; Life Technologies) in a total reac-
tion volume of 25 μl. Real-time PCR cycles consisted of:
10 minutes at 95°C for polymerase activation, 40 cycles of
15 seconds at 95°C, 15 seconds at 60 to 68°C, 45 seconds at
68°C; and for the Gata4, Mef2c, Myh6, Nkx 2.5, Tnnt2:
10 minutes at 95°C for polymerase activation, 40 cycles of
15 seconds at 95°C and 60°C for 1 minutes. GAPDH was
amplified to serve as an intrinsic control. The data were ana-
lyzed by the Pfaffl method [20]. The details of the primers
used are given in Table 1.
Western blot
Murine iPS-CMs cells were lysed in SDS lysis buffer
supplemented with complete proteinase inhibitor cocktail
and PhosSTOP phosphatase inhibitor cocktail tablets
(Roche Diagnostics, Mannheim, Germany). Proteinconcentration was determined by BCA protein assay
(Thermo Scientific, Bonn, Germany). Aliquots containing
equal amounts of proteins (20 to 30 μg) were resolved
by 10% SDS-PAGE and transferred onto nitrocellulose
membranes (Karl Roth, Karlsruhe, Germany). Membranes
were blocked and incubated with monoclonal mouse anti-
total-protein and rabbit anti-phospho-protein primary
antibodies overnight at 4°C: PKCε (1:500, cat. no. sc-214,
Santa Cruz Biotechnology, Dallas, Texas, USA), Akt
(1:2000, cat. no. 2920, Cell Signaling, Danvers, Massachusetts,
USA), phospho-Akt (Ser473, 1:2000, cat. no. 4060, Cell Sig-
naling), STAT3 (1:1000, cat. no. 9139, Cell Signaling), and
phospho-STAT3 (Tyr705, 1:2000, cat. no. 9145, Cell Signal-
ing). GAPDH served as a loading control (1:1000, cat. no.
2118, Cell signaling). After 1 hour incubation with IRDye®
conjugated secondary antibodies (Li-Cor Bioscience, Bad
Homburg, Germany), blots were analyzed using the infrared
imaging system and software Odyssey® from Li-Cor Bioscience
and quantified by ImageJ software.
Statistical analysis
For every analysis, at least three independent experiments
were performed, each done in triplicate. Data are presented
as mean value ± SEM. Data from two independent groups
of samples were compared using Student’s t test. Three or
more groups of samples were compared using one-way
analysis of variance with Bonferroni post-hoc analysis. A
P value ≤0.05 was considered statistically significant. Tests
were carried out using IBM SPSS Statistics 20 software
(IBM, Armonk, NY, USA).
Results
Induced pluripotent stem cell-derived cardiomyocyte
differentiation
Spontaneously beating, GFP-positive areas in EBs were first
observed on days 8 to 9 of differentiation (Figure 1B). After
puromycin selection, the remaining cell clusters were com-
posed exclusively of GFP-positive cells, which represented
more than 95% of all viable cells as determined by flow
cytometry of enzymatically dissociated clusters at day 16
(Figure 1C). When these cells were plated and cultured
for an additional 5 days on fibronectin-coated plates in the
presence of puromycin, they all stained positive for cardiac
sarcomeric protein α-actinin (Figure 1D).
Induced pluripotent stem cell-derived cardiomyocyte
phenotype and function
As demonstrated by electron microscopy (Figure 2), the
ultrastructure of iPS-CMs mirrored that of late embryonic
and neonatal naïve CMs, and the maturation process had
clearly not reached the level of adult CMs. By light micros-
copy, cell size was similar between iPS-CMs and N-CMs,
and the small percentage of binucleated cells confirmed the
relative immaturity of both cell types (Figure 3A-C). The
Table 1 Primers used for real-time quantitative PCR
Gene Primer sequence (5′→3′) Annealing temperature (°C) Reference
Hif 1α Fw: CATGATGGCTCCCTTTTTCA 63 [55]
Rev: GTCACCTGGTTGCTGCAATA
Hif 2α Fw: GGGAACACTACACCCAGTGC 63 [55]
Rev: TCTTCAAGGGATTCTCCAAGG
Vegf Fw: ACTGGACCCTGGCTTTACTG 63 [56]
Rev: TCACTTCATGGGACTTCTGC
Glut-1 Fw: GCTTCCTGCTCATCAATCGT 63 [56]
Rev: CTTCTTCTCCCGCATCATCT
HSP70 Fw: TGGTGCTGACGAAGATGAAG 63 [57]
Rev: AGGTCGAAGATGAGCACGTT
PKCδ Fw: CAGACCAAGGACCACCTGTT 63 [58]
Rev: GCATAAAACGTAGCCCGGTA
PKCε Fw: GAGGACTGGATTGACCTGGA 63 [58]
Rev: ATCTCTGCAGTGGGAGCAGT
PKCθ Fw: ATGGACAACCCCTTCTACCC 63 [58]
Rev: GCGGATGTCTCCTCTCACTC
Bcl2 Fw: TGTGTGTGGAGAGCGTCAACA 65 [59]
Rev: TGCCGGTTCAGGTACTCAGTC
Bax Fw: GCGTGGTTGCCCTCTTCTACTTTG 65 [60]
Rev: AGTCCAGTGTCCAGCCCATGATG
Bad Fw: GGGAGCAACATTCATCAGCAGG 65 [60]
Rev: CATCCCTTCATCCTCCTCGGTC
Bcl-xL Fw: AACATCCCAGCTTCACATAACCCC 65 [60]
Rev: GCGACCCCAGTTTACTCCATCC
P53 Fw: ATTTGTATCCCGAGTATCTG 63 [56]
Rev: GGTATACTCAGAGCCGGCCT
Fas Fw: AGGACTGCAAAATGAATGGG 60 [61]
Rev: GGGTGCAGTTTGTTTCCACT
FADD Fw: GGGGACTCATCCTGTTTTCT 60 [62]
Rev: ATGCATAGTCTGGGGAGTCA
Gata4 Fw: AATGCCTGTGGCCTCTATCA 60 [63]
Rev: GGTCTCGCTCCTGGAAGATG
Mef2c Fw: ATTTGGGAACTGAGCTGTGC 60 [63]
Rev: CGCTCATCCATTATCCTCGT
Myh6 Fw: CCAACACCAACCTGTCCAAGT 60 [64]
Rev: AGAGGTTATTCCTCGTCGTGCAT
Nkx2.5 Fw: CCAGAACCGTCGCTACAAGT 60 [65]
Rev: GGGTAGGCGTTGTAGCCATA
Tnnt2 Fw: GCCAAAGATGCTGAAGAAGG 60 [66]
Rev: TTCTCGAAGTGAGCCTCGAT
Gapdh Fw: GGGGACTCATCCTGTTTTCT 60 [64]
Rev: ATGCATAGTCTGGGGAGTCA
Fw, forward; Rev, reverse.
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Figure 2 Transmission electron microscopy. (A) Murine late embryonic (E16.5), (B) neonatal, and (C) induced pluripotent stem cell-derived cardiomyocytes
(iPS-CMs; day 18 of differentiation). For comparison, (D) shows cardiomyocytes in an adult mouse heart. Myofibrils with typical cross striations surrounded
by mitochondria are present in all cells but are densely packed and organized only in adult cardiomyocytes. The morphology of iPS-CMs is similar to that
of late embryonic/early neonatal cardiomyocytes. m, Mitochondria; n, nucleus; z, sarcomeric z-line.
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Figure 3 Phenotypic features of induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes (N-CMs). (A,B)
Sarcomeric alpha-actinin staining of iPS-CMs and N-CMs 5 days after plating taken at individually adjusted exposure intensity. Nuclei are DAPI
stained, scale bar 100 μm. (C) Percentage of binucleated cells. (D) Expression of selected genes relevant for cardiomyocyte development
determined by real-time PCR. *P < 0.05.
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Brodarac et al. Stem Cell Research & Therapy  (2015) 6:83 Page 9 of 19mRNA expression pattern of selected genes that are relevant
to CM development was heterogenous (Figure 3D). Of the
earlier transcription factors, Nkx2.5 was higher in iPS-CMs
than in N-CMs, Gata4 was lower and Mef2c similar.
Among genes encoding for mature contractile proteins,
Myh6 was higher in iPS-CMs and Tnnt2 was not signifi-
cantly different. Overall, expression level variability
(that is, standard error) was higher in iPS-CMs, indicat-
ing the heterogeneity and ongoing maturation within
the reprogrammed cell population. Current clamp re-
cordings indicated that both iPS-CMs and N-CMs
displayed ventricular-, atrial-, and nodal-like AP morph-
ologies (Figure 4A). Both iPS-CMs and N-CMs showed
similar maximum diastolic potential and amplitude
(Figure 4B). However, the beating frequency and AP
duration at 90% of repolarization (APD90) were signifi-
cantly different, with the frequency being lower (5.10 ±
2.47 Hz) and the APD90 longer (60.53 ± 8.30 ms) in
N-CMs than in iPS-CMs (8.41 ± 2.44 Hz and 34.19 ±Figure 4 Electrophysiology properties of neonatal cardiomyocytes (N-CMs)
(A) Current clamp recordings revealed differentiation of neonatal cells into
Comparison of action potential parameters measured from N-CMs and iPS-
Dotted lines indicate 0 mV membrane potential (A) or population means (B
both cell types. MDP, maximum diastolic potential; APD90, action potential8.33 ms; both P > 0.05; Figure 4B). iPS-CMs responded
to the adrenergic agonist isoproterenol with increased
beating frequency, whereas the muscarinergic agonist
charbachol exerted a negative chronotropic effect
(Figure 5A). Both effects could be reversed upon wash-
out. Overall, AP tracings of N-CMs were comparable
(Figure 5B), but the response to pharmacological agents
could not be determined due to cell instability shortly
after gigaseal formation (data not shown). iPS-CMs also
displayed intact excitation-contraction coupling as indi-
cated by simultaneous recordings of intracellular cal-
cium transients (Fura 2-AM fluorescence ratio (R340/380))
and cellular contraction/shortening, but the slow upstroke
of the calcium transients confirmed their relative imma-
turity (Figure 6A). The quantitative data on calcium
transient morphology and dynamics, averaged from 35
individual recordings, are given in Figure 6B and confirm
the fetal/neonatal character of the iPS-CMs. In line with
this notion, the basal respiration rate in iPS-CMs wasand induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs).
atrial and ventricle-like action potentials from cardiomyocytes. (B)
CMs. Solid lines through distributions indicate population means.
), respectively. Data were compared using t-test. *P < 0.05 between
duration at 90% of repolarization.
Figure 5 Functional characteristics of induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes (N-CMs).
(A) Representative action potential (AP) recording traces of iPS-CMs showing the positive and negative chronotropic response to isoproterenol
and carbachol application, respectively. (B) AP recordings from spontaneously beating N-CMs.
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measurements, the ATP synthase inhibitor oligomycin
was added to differentiate the ATP-linked respiration
(123 ± 35 pmoles/minute) from the proton leak (29 ± 12
pmoles/minute). The addition of the uncoupling agent
FCCP increased the OCR by iPS-CMs to 236 ± 21
pmoles/minute (maximal respiration) and revealed a re-
sidual respiratory capacity of 35 ± 21 pmol/minute. The
rate of oxygen consumption due to non-mitochondrial
sources was assessed by addition of complex I and III
inhibitors rotenone and antimycin A, respectively, and
shown to be 49 ± 11 pmol/minute.Induced pluripotent stem cell-derived cardiomyocyte
hypoxia and glucose/serum deprivation in vitro model
In the presence of serum and glucose, hypoxia alone for up
to 7 hours did not lead to a markedly increased proportion
of poly-caspase active iPS-CMs compared to cells incubated
in full medium (15% FBS and high glucose) at 21% O2
(Figure 1E). Similarly, hypoxia and concomitant withdrawal
of either serum or glucose alone did not significantly influ-
ence the number of poly-caspase-positive cells. However,
iPS-CMs cultured at 1% O2 in serum- and glucose-deprived
medium displayed a relevant time-dependent increase in
the number of poly-caspase active cells, and 48 ± 3% were
poly-caspase-positive after 3 hours incubation in combinedhypoxia and GSD (P= 0.001 versus baseline). After 5 hours,
67 ± 2% (P = 0.006 versus 3 hours) and, after 7 hours, 96 ±
2% of the iPS-CM were stained positive (P = 0.0003 versus
5 hours; Figure 1E). Similarly, the MTS conversion rate
dropped by 67 ± 3.3% after 3 hours, 73 ± 0.5% after 5 hours,
and 77 ± 2% after 7 hours hypoxia/GSD (Figure 8A). We
therefore chose 3 hours hypoxia and GSD as the model for
all subsequent experiments, as it leaves sufficient room for
the detection of both an improvement and worsening of the
outcome.Neonatal cardiomyocyte and induced pluripotent stem
cell-derived cardiomyocyte response to hypoxia and
glucose/serum deprivation
There were distinct differences between iPS-CMs and
N-CMs regarding the preservation of metabolic activity in
hypoxia/GSD. Cytosolic and mitochondrial oxidoreductase
activity was reduced by 67 ± 3.3% in iPS-CMs, but did not
change in N-CMs after 3 hours hypoxia/GSD (−0.014 ±
1.8%; P < 0.001; Figure 8A). We therefore followed
oxidoreductase activity for longer periods of hypoxia GSD
and found that it dropped by 73 ± 0.5% in iPS-CMs and by
20 ± 6.5% in N-CMs after 5 hours (P < 0.001), and by 77 ±
2% in iPS-CMs and 42 ± 3.1% in N-CMs after 7 hours
(P < 0.001), confirming a higher sensitivity to hypoxia/GSD
of iPS-CMs throughout the experimental protocols
Figure 6 Calcium transient analysis in induced pluripotent stem cell-derived cardiomyocytes. (A) Representative recordings of Fura-2-AM fluorescence
ratio at 340/380 nm excitation wavelengths and cell shortening. (B) Quantitative analysis of intracellullar calcium transient dynamics. R is the Fura 2-ratio
at 340/360 nm. Rmax, maximal systolic calcium amplitude (the difference of R-systolic and R-diastolic); +dR/dt, maximal rate of fluorescence rise during
sytole; −dR/dt, maximal rate of fluorescence decay during diastole; TTP50%, time to 50% peak (in ms); TTB50%, time to 50% baseline (ms). Data are
means ± SEM, N = 35; cells studied in three independent experiments.
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levels, which were similar in iPS-CMs and N-CMs in
normoxic control conditions (Figure 8B). During 3 hours
hypoxia/GSD, however, cytoplasmic ATP decreased by 83 ±
0.9% in iPS-CMs and by 61 ± 0.4% in N-CMs (P < 0.001).
In contrast to iPS-CMs, which reacted to 3 hours hypoxia
and GSD by a 48 ± 3% increase of poly-caspase active cells,
only 23 ± 2% of the N-CMs displayed poly-caspase activity
after exposure to the same conditions (P = 0.002; Figure 9).
Regarding the differential activation of initiator versus ef-
fector caspases, hypoxia/GSD primarily led to activation of
caspase-8 in iPS-CMs (P = 0.03) but not in N-CMs (P = 0.3;
Figure 9C). Compared to normoxic controls, caspase-9
activity did not change significantly in either iPS-CMs or
N-CMs, while caspase-3/7 activity was similarly reduced in
both cell types (iPS-CMs: P = 0.003; N-CMs: P = 0.003).
With respect to advanced apoptotic or necrotic cell death
with loss of plasma membrane integrity, 2 ± 0.16% of the
iPS-CMs and 1.9 ± 0.09% of the N-CMs stained positive for
7-AAD in normoxic control medium (P = 0.47). Inhypoxia/GSD, however, 10.3 ± 1.7% of the iPS-CMs dis-
played plasma membrane disruption with nucleotide stain-
ing by 7-AAD, while only 2.7 ± 0.06% of the N-CMs were
7-AAD-positive (P = 0.01; Figure 9B). By TUNEL staining,
DNA fragmentation increased by 16.5 ± 0.8% in the
iPS-CMs in response to hypoxia/GSD, but only by 2.5 ±
2.4% in the N-CMs (P = 0.001; Figure 9D). Since apoptotic
cell death is preceded by breakdown of the mitochondrial
membrane potential, we assessed the mitochondrial mem-
brane potential using TMRM. As shown in Figure 10,
TMRM accumulated in hyperpolarized mitochondria when
iPS-CMs or N-CMs were subjected to normoxic control
conditions. In hypoxia/GSD, TMRM fluorescence intensity
was reduced by 35 ± 0.8% (P < 0.001) for iPS-CMs. This
was not the case for N-CMs (reduction by 4.6 ± 0.8%;
P = 0.47). Breakdown of mitochondrial membrane potential
in many cells was also visualized using the fluorescent indi-
cator JC-1. As shown in Figure 11, granular staining indi-
cates mitochondrial JC-1 aggregates in hyperpolarized
mitochondria when iPS-CMs or N-CMs were subjected to
Figure 7 Analysis of mitochondrial respiration of induced pluripotent stem cell-derived cardiomyocytes using the Seahorse XF Cell Mito Stress Kit. (A)
Oxygen consumption rate (OCR) under basal and under different conditions of mitochondrial stress that was induced by addition of substances indicated
on top of the panel. Three cycles of measurements were performed for each condition. (B) Individual mitochondrial function parameters calculated from the
data shown in (A). Data in (A) and (B) are shown as mean± SEM for n = 7 replicates. FCCP, carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; non-Mito,
non-mitochondrial oxygen consumption.
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iPS-CMs displayed a diffuse staining pattern, indicating
a significant reduction of the mitochondrial membrane
potential in 35 ± 2% iPS-CMs. Again, this was not the case
for N-CMs (0.37 ± 0.3%; P < 0.001; Figure 11B). ROS are
known to mediate much of the cellular damage done
during actual and simulated ischemia. ROS fluorescence in-
tensity increased by 16.4 ± 2.5% (P = 0.005) in “ischemic”
iPS-CMs in comparison to iPS-CMs cultured in normoxia,
while ROS fluorescence intensity in “ischemic” N-CMs was
increased by 7.1 ± 2% (P = 0.1; Figure 12B). In normoxia,Figure 8 Effect of hypoxia and nutrient deprivation on metabolic activity of ind
cardiomyocytes (N-CMs). (A) Activity of cellular oxidoreductases in iPS-CMs and
data. *P≤ 0.05, for iPS-CMs versus normoxia (Bonferroni test); #P≤ 0.05, versus d
test); ##P< 0.001, iPS-CMs versus N-CMs by analysis of variance. (B) ATP content
normoxia (0 hours, Bonferroni test); #P≤ 0.05, versus N-CMs. (C) Average numbesignificant differences in oxidative stress between iPS-CMs
and N-CMs were not detected (P = 0.24).
Cytoprotective effect of mesenchymal stromal
cell-conditioned medium
To determine whether paracrine factors secreted by MSCs
can counteract the increased susceptibility of iPS-CMs to
hypoxia/GSD, cells were cultured in the presence of MSC-
CoM or equivalent non-conditioned, glucose/serum-
deprived control medium. To test whether medium
conditioned by standard fibroblasts (FB-CoM) exertsuced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal
N-CMs determined by MTS assay, normalized to normoxia/full medium
ifferent hypoxia and glucose/serum deprivation (GSD) durations (Bonferroni
in iPS-CMs and N-CMs determined by CellTiter Glo assay. *P≤ 0.05, versus
r of iPS-CMs and N-CMs per well.
Figure 9 Response of murine induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes (N-CMs) to in vitro hypoxia and
nutrient deprivation. (A) Representative photomicrographs (scale bar 100 μm) and (B) quantitative analysis of poly-caspase-positive, 7-aminoactinomycin D
(7-AAD)-positive iPS-CMs and N-CMs after 3 hours incubation in hypoxia and glucose/serum deprivation (GSD) (#P≤ 0.05, versus normoxia/full medium).
(C) Caspase-8, -9, and 3/7 activities in iPS-CMs and N-CMs after 3 hours incubation in hypoxia/GSD. Data are normalized to those normoxia controls. *P≤ 0.05,
versus normoxia/full medium; #P≤ 0.05, iPS-CMs versus N-CMs in hypoxia/GSD. (D) Increase in TUNEL-positive cells after 3 hours incubation in hypoxia/GSD
(#P= 0.001). FBS, fetal bovine serum.
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in the presence of FB-CoM. As determined by MTS assay,
MSC-CoM enhanced the oxidoreductase activity of
iPS-CMs and N-CMs 1.27 ± 0.1-fold and 1.36 ± 0.17-
fold, respectively (iPS-CM, P = 0.01; N-CMs, P = 0.05;
Figure 13A), while FB-CoM had a less pronounced
effect on oxidoreductase activity (iPS-CMs: P = 0.01; N-
CMs: 1.05 ± 0.01-fold, P = 0.0001). In iPS-CMs, MSC-
CoM also led to increased cytosolic ATP levels after
3 hours hypoxia/GSD (1.26 ± 0.1-fold, P = 0.009), and
this effect was also observed in the presence of FB-CoM
(1.35 ± 0.12-fold, P = 0.01), but not in N-CMs (MSC-
CoM; P = 0.27, FB-CoM: P < 0.001; Figure 13B).Signaling response of induced pluripotent stem
cell-derived cardiomyocytes to mesenchymal stromal
cell-conditioned medium
As assessed by real-time PCR, Hif1α, Glut-1, and VEGF
transcripts were not significantly changed following
hypoxia/GSD, and MSC-CoM did not induce the
expression of these genes either (Figure 13C). The
expression of mRNA encoding for PKCε (P = 0.01), anti-
apoptotic genes Bcl-2 (P = 0.05) and Bcl-xL (P = 0.003),
and proapoptotic Bad (P = 0.02) was significantly
reduced in cells exposed to hypoxia/GSD, while tran-
scripts of the proapoptotic Bax gene were not affected.
The expression ratios of Bax/Bcl-2 and Bad/Bcl-xL,
Figure 10 Mitochondrial potential analysis in induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes (N-CMs).
(A) Representative images of tetramethylrhodamine methyl ester (TMRM) staining of iPS-CMs and N-CMs after 3 hours hypoxia and glucose/serum
deprivation (GSD) compared to normoxia control (21% O2, 15% fetal bovine serum and high glucose). Scale bar 100 μm. (B) Quantification of TMRM
fluorescence intensity of cells cultured in normoxia versus cells cultured in hypoxia and GSD (#P < 0.001, versus normoxia control; ##P < 0.001, iPS-CMs
versus N-CMs in normoxia).
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apoptosis, increased by 2.41 ± 0.67-fold (Bax/Bcl-2,
P = 0.053) and 2.34 ± 0.23-fold (Bad/Bcl-xL, P = 0.59) in
hypoxia/GSD. The presence of MSC-CoM had no influ-
ence on the expression of the above-mentioned genes.
However, iPS-CMs exposed to hypoxia/GSD displayed
significantly upregulated Hsp70 mRNA levels (P = 0.04)
and MSC-CoM further increased its expression (P = 0.006,
versus normoxic control; P = 0.049, versus hypoxia/GSD).
Proteins mainly regulated by phosphorylation wereFigure 11 Mitochondrial potential analysis in induced pluripotent stem ce
(N-CMs). (A) Representative images of JC-1 staining of iPS-CMs and N-CMs
to normoxia control (21% O2, 15% fetal bovine serum and high glucose) (
#
shrinking in cells with diffuse JC-1 staining. (B) Proportion of cells with diffu
(#P ≤ 0.01). GFP, green fluorescent protein; JC-1, 5,5′,6,6′-tetrachloro-1,1′,3,3′-quantified by Western blotting with and without
phospho-specific antibodies. Here, hypoxia/GSD signifi-
cantly reduced the p-STAT3/STAT3 ratio in iPS-CMs
(P = 0.004), while MSC-CoM efficiently preserved STAT3
phosphorylation (P = 0.03; Figure 14). Total PKCε was re-
duced in cells exposed to hypoxia/GSD (P = 0.01), but was
restored to near-normal levels in the presence of MSC-
CoM (P = 0.05). The p-Akt/Akt ratio did not change sig-
nificantly during hypoxia/GSD and was not affected by
co-incubation with MSC-CoM (P = 0.8).ll-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes
after 3 hours hypoxia and glucose/serum deprivation (GSD) compared
P < 0.01, versus normoxia control). Scale bar 100 μm. Note the nuclear
se JC-1 staining expressed as % of cells versus normoxia/full medium
tetraethylbenzimidazol-carbocyanine iodide.
Figure 12 Reactive oxygen species (ROS) expression analysis. (A) Representative images of ROS accumulation in cells with exacerbated oxidative
stress, visualized using the CellROX assay®. In induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes (N-CMs)
after 3 hours hypoxia and glucose/serum deprivation (GSD) compared to normoxia control (21% O2, 15% fetal bovine serum and high glucose). Scale
bar 100 μm. (B) Quantification of oxidative stress (CellROX® fluorescence intensity) in iPS-CMs and N-CMs cultured in normoxia versus those cultured in
hypoxia and GSD (#P = 0.005, versus normoxia control; ##P = 0.002, iPS-CMs versus N-CMs in hypoxia).
Figure 13 Effect of mesenchymal stromal cell-conditioned medium (MSC-CoM) and fibroblast-conditioned medium (FB-CoM) on metabolic activity and
gene expression in hypoxia. (A) MSC-CoM and FB-CoM effects on the activity of cytosolic and mitochondrial oxidoreductases determined by MTS assay, and
(B) MSC-CoM and FB-CoM effects on ATP content in induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) and neonatal cardiomyocytes (N-CMs).
Data are normalized for respective average of hypoxia and glucose/serum deprivation (GSD) control experiments without MSC-CoM. *P≤ 0.05, versus
hypoxia/GSD controls. (C) Effect of hypoxia on expression of stress response genes in iPS-CMs incubated in standard or MSC-CoM in hypoxia/GSD. Data are
shown as fold-change relative to the expression in normoxia/full medium (=1). *P≤ 0.05, versus normoxia/full medium; #P≤ 0.05, control versus MSC-CoM.
**P≤ 0.05, overall by analysis of variance.
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Figure 14 Western blot analysis of STAT3, p-STAT3, Akt, p-Akt and PKCε. (A) Representative immunoblots of STAT3, p-STAT3, Akt, p-Akt and PKCε expression
in induced pluripotent stem cell-derived cardiomyocytes in normoxia/full medium (21% O2, + fetal bovine serum (FBS) + glucose), in hypoxia and glucose/
serum deprivation (GSD) (1% O2; −FBS, −glucose), and in hypoxia/GSD with mesenchymal stromal cell-conditioned medium (MSC-CoM) (1% O2; +MSC-CoM).
(B-D) Corresponding densitometry data of hypoxia/GSD with and without MSC-CoM, expressed as the fold-change compared to normoxia/full medium data.
*P≤ 0.05, versus normoxia/full medium; #P≤ 0.05, versus MSC-CoM.
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So far, somatic stem cell therapy for heart repair has yielded
disappointing clinical results [21], mainly because the cap-
acity of non-pluripotent progenitors to re-create contractile
cells upon transplantation in the failing heart has been
overestimated. In this context, induced pluripotent stem
cell technology offers the possibility to create large numbers
of syngeneic CMs for potential clinical transplantation in
the failing heart. Although there are concerns regarding the
genetic stability of reprogrammed cells and their progeny
[22,23], there are currently few, if any, conceptually sound
alternatives for re-generation of contractile myocardium.
iPS-CMs where previously shown to possess all the baseline
phenotypic and functional characteristics of both CMs
derived from embryonic stem cells and those isolated from
neonatal myocardium [8-10,24,25], but little is known
about their behavior in a hostile environment as it is en-
countered in a diseased heart.
We found that exposure to hypoxia combined with
GSD,as a model of “simulated in vitro ischemia” led within
3 hours to caspase activation in almost 50% of the iPS-
CMs, associated with an increased proportion of necrotic
and TUNEL-positive cells, breakdown of the mitochondrial
membrane potential in one third of the cells, increased ac-
cumulation of ROS, and a reduction of the average oxidore-
ductase activity by more than 60%. These findings mirror a
substantial cell damage and are in line with studies showing
that dying cells display characteristics of apoptosis, autoph-
agy and necrosis at the same time [26]. Overall, N-CMs ap-
peared to be less sensitive to these conditions because they
exhibited less caspase activation, a minimal increase in thepercentage of necrotic, TUNEL-positive cells and ROS ex-
pression, preserved mitochondrial membrane potential and
a delayed and less pronounced loss of oxidoreductase activ-
ity. In line with these findings, caspase-8, which is an essen-
tial component of the extrinsic cell death pathways, was
activated only in iPS-CMs but not in murine N-CMs after
3 hours hypoxia/GSD. Chao and colleagues showed that rat
N-CMs activated caspase-8 after 4 hours exposure to hyp-
oxia and serum deprivation [27], so that our finding of a 3-
hour period of relative resistance to hypoxia/GSD in mur-
ine N-CMs appears realistic. On the other hand, caspase-9
activity did not increase and caspase-3 activity was reduced
in both iPS-CMs and N-CMs. The initiator caspase-9
is a key component of the mitochondrial death pathway
and would be expected to play an even greater role in cell
death secondary to hypoxia/GSD [18,28,29]. This intrinsic
apoptosis-initiating pathway is typically initiated by opening
of the mitochondrial permeability pore when oxidative me-
tabolism breaks down, with the latter being confirmed
by our findings regarding the mitochondrial membrane
potential. However, apoptosis in “ischemia-like” situations
may also occur independently of the intrinsic pathway
in a process involving “extrinsic” caspase-8 activation. For
instance, Schamberger and colleagues demonstrated that
in rat embryonic cells caspase-8 seemed to be sufficient
to initiate the serum starvation-induced apoptosis while
the caspase-9 activation was impaired by sequestration
of caspase-9 to cytoskeletal structures [30]. Our finding of
downregulated effector caspase-3/7 activity in both iPS-
CMs and N-CMs underscores the relatively early stage of
apoptosis induction in the majority of the cells or the non-
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these conditions, as has been described for several other cel-
lular systems [31-33].
The key question is whether the increased susceptibility
to hypoxia/GSD compared to N-CMs is a phenomenon
caused by reprogramming, or reflects differences in CM
maturity. As Keung and colleagues have recently summa-
rized [9], controlling iPS-CM maturation is exceedingly
important in order to provide a uniform cell product with
stable characteristics for therapeutic or advanced research
applications. We used cells collected at differentiation day
21, which are expected to have matured beyond the fetal
stage. However, several of the assays we performed regard-
ing calcium handling, cytoplasmic membrane potential
and mitochondrial respiratory function indicate that at
least a proportion of our iPS-CM population, although
produced and purified using a highly standardized proto-
col, are more immature. Calcium transients of the iPS-
CMs resemble calcium transients observed in primary
neonatal mouse CMs [34] or mouse embryonic stem cell-
derived cardiomyocytes (ESC-CMs) [35]. However, com-
pared with primary adult mouse CMs [36,37], calcium
transients of iPS-CMs had reduced systolic maximal
calcium as well as rates of both fluorescence rise during
systole and decay during diastole. Electrophysiological
data indicate that iPS-CMs display properties as described
previously for fetal CMs and ESC-CMs [10,38,39] and the
Seahorse data suggest that iPS-CMs exhibit an active
metabolic profile that is comparable to that reported for
human iPS-CMs [40] and murine N-CMs [41-43]. Never-
theless, the comparison with N-CMs appears justified to
us, since many functional and morphologic similarities
have been previously reported and were also confirmed in
our study. In the end, individual CMs developing in an
artificial in vitro setting may display differing degrees of
maturity, so that uniformity would be reached only when
all cells have completely matured. Of note, Boheler and
colleagues recently showed that the viability of ESC-CMs
obtained at differentiation day 10 decreased as late as after
48 hours exposure to 0.5% O2 and serum and glucose
deprivation [7]. At that point, more than 70% of the
immature ESC-CMs were still viable, while late-stage
ESC-CMs obtained on differentiation day 18 were much
more sensitive to “simulated ischemia”. It has been well
documented that CMs isolated from fetal hearts are less
sensitive to hypoxia/ischemia than those from neonatal
hearts [44]. Comparison with mature/adult CMs is prob-
lematic because naïve adult CMs are difficult to culture, but
intact neonatal hearts have been shown to be more sensitive
to ischemia than mature hearts [45]. Nevertheless, our data
allow us to conclude that murine iPS-CMs created with this
well-established protocol, which has been used in numerous
experimental settings [14,46,47], have a distinct deficit re-
garding their tolerance to “simulated ischemia” that needs tobe taken into account when interpreting outcome data and
requires countering measures.
One such measure may be the preceding or concomitant
incubation with MSCs or, as in our experiments, with
MSC-CoM. We have shown previously that MSC-CoM in-
creases the hypoxia/GSD tolerance of the CM-like HL-1
cells [48], and other groups demonstrated the efficacy of
this approach in intact ischemic hearts [49,50]. MSC-CoM
increased the cellular redox activity in iPS-CMs subjected
to hypoxia/GSD approximately 1.3-fold, a modest but pos-
sibly relevant improvement which might be further en-
hanced by concentrating the medium or adding live MSCs
[14]. FB-CoM did only partially mimic the cytoprotective
effects of MSC-CoM, which emphasizes the ‘beneficial’ spe-
cificity of MSC-released paracrine factors. On the molecu-
lar level, our model did not induce mRNA expression of
hypoxia-inducible genes such as Hif1α,Vegf and Glut-1, but
Hsp70 transcription was upregulated and further aug-
mented in the presence of MSC-CoM. This is in line with
other studies showing that heat shock proteins support the
survival of cells exposed to environmental stress [51-53], as
well as with reports showing that HSP70 promotes CM
survival by inhibiting pro-apoptotic pathways that include
caspase- and Fas-mediated death cascades [54]. Further-
more, Bcl-2, Bcl-xL and Bad transcripts were reduced in
hypoxia while the Bax/Bcl-2 and Bad/Bcl-xL ratio in hyp-
oxia increased, which agrees with the increased caspase
activity that we detected. Regarding the canonical kinase
signaling pathways, MSC-CoM in our study prevented
reduction in PKCε protein levels and restored STAT3 phos-
phorylation to almost basal levels, confirming the activation
of cell survival pathways by paracrine factors that were
also shown to mediate the MSC-CoM response in other
myocyte cell types [48].
Limitations
The simulated ischemia model we used in these in vitro ex-
periments is clearly only a rudimentary representation of the
situation present in an ischemic heart. Moreover, we con-
centrated on the damage induced by “simulated ischemia”
alone but did not perform experiments that mimic reperfu-
sion/reoxygenation injury. Also, our iPS-CM population was
genetically modified and purified by antibiotic selection,
while the N-CMs we used were naïve cells. While N-CM
purity was originally confirmed to be high, it cannot be ruled
out that during longer cultivation periods the proportion of
proliferative non-CM cells increased.
Conclusions
In summary, we demonstrated that 3 hours hypoxia and
GSD provoke cell stress and damage in iPS-CMs that ex-
ceeds that of naïve N-CMs, although the iPS-CMs we used
showed several aspects of less mature CMs, which are con-
sidered to be more resistant to hypoxia and/or ischemia.
Brodarac et al. Stem Cell Research & Therapy  (2015) 6:83 Page 18 of 19While the reasons for this increased susceptibility are not
entirely clear, a translationally practical approach to influ-
ence it may be the concomitant treatment with MSC-CoM
via HSP70 expression, preservation of PKCε-dependent sig-
naling cascades and further activation of STAT3-dependent
signaling cascades. Ultimately, this strategy may help im-
prove the efficacy of regenerative therapies involving CMs
derived from iPS cells.Note: This article is part of a thematic series on Cardiovascular
regeneration edited by Ronald Li. Other articles in the series can
be found online at http://stemcellres.com/series/cardiovascular.Abbreviations
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